Browse Infectious Disease Topics Articles by Topic

FDA Issues Emergency Use Authorization for Bamlanivimab

While the search for a vaccine continues, the agency adds to the list of stop-gap therapeutics to battle COVID-19.

AMA Prepares for COVID-19 Vaccine with Coding Updates

Laying the administrative groundwork is an important part of ensuring success for administration of an eventual vaccine.

Remdesivir Injection (Veklury)

Remdesivir’s benefit appears to be modest, but may be better for those receiving low-flow oxygen.

Can Chopsticks Carry SARS-CoV-2?

This small study suggests salivary contamination of utensils with SARS-CoV-2 virus can occur. Sharing food and utensils, or using communal food bowls, probably is not a good idea if one is trying to avoid COVID-19.

Possible Aerosol Spread of SARS-CoV-2 in an Apartment Building

Although not definitive, evidence is consistent with aerosol spread of SARS-CoV-2 in an apartment building as a result of transport through the drainage system to apartments directly above.

A Novel Rifabutin-Containing Combination Regimen Eradicates H. pylori Infection

Researchers found a significantly higher eradication rate for H. pylori with a 14-day regimen of rifabutin, amoxicillin, and omeprazole compared to 14 days of amoxicillin and omeprazole.

COVID-19 Vaccine Update

There are dozens of vaccine candidates undergoing investigation in human and animal trials. Only a few have reached Phase III testing. This is a closer look at those.

Gut Microbiome in Patients at Risk for Parkinson’s Disease

Certain risk factors and prodromal markers of Parkinson’s disease (PD), such as constipation and rapid eye movement sleep behavior disorder, are associated with specific bacterial compositions of the gut. However, the value of gut microbiome data to predict the risk of PD development needs further investigation.

Antibiotic Use in COVID-19 Patients

Fifty-seven percent of patients with COVID-19 infection treated at 38 hospitals in Michigan received early empiric antibiotics, although researchers documented community-onset bacterial coinfection in only 3.5%.

HHS Releases Latest Iteration of Antibiotic Resistance Action Plan

The five-point strategy crafted in previous years remains the same, but the tactics have improved to help execute the goals. The new plan includes details about stronger and more evidence-based activities that have reduced antibiotic resistance that public health officials can lean on to drive progress.